Skip to main content
. Author manuscript; available in PMC: 2015 Jan 17.
Published in final edited form as: Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Oct;36(10):927–938. doi: 10.3969/j.issn.1672-7347.2011.10.002

Tab. 1.

Clinically relevant substrates of MRP1/ABCC1 *

Type of substrates Examples
Drugs Anticancer drugs
Vinca alkaloids: vinblastine and vincristine
 Epipodophyllotoxins: etoposide (VP-16) and teniposide
 Camptothecins: topotecan, irinotecan and SN-38
 Methotrexate and mitoxantrone
Other drugs
 Anti HIV drugs; ritonavir and saquinavir
 Antibiotics: difloxacin and grepafloxicin
 Tyrosine kinase inhibitors: imatinib mesylate and gefitinib
Heavy metal anions Arsenite
Arsenate
Trivalent and pentavalent antimonials
Glutathione conjugates(-GS) Dinitrophenyl-GS
Etacrynic acid-GS
Doxorubicin-GS
Cyclophosphamide-GS
Melphalan-GS
Aflatoxin B1-epoxide-GS
Hydroxynonenal-GS
Prostaglandin A2-GS
Glutathione (GSH, GSSG)
Glucuronide conjugates (-G) Bilirubin-G
Estradiol 17βD-G
Hyodeoxycholate-G
Etoposide (VP-16)-G
NS-38-G
Sulfate conjugates (-S) Estrone-3-S
Taurocholate-3-S
Dehydroepiandrosterone-3-S
Sulfatolithocholyl taurine
Folates Folic acid
L-leucovorin
Toxicants Aflatoxin B1
Methoxychlor
Fenitrothion
Others Leukotrienes C4, D4 and E4
Curcuminoids
Calcein
*

The primary references are available from the following reviews. [1, 10, 19, 71]